Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

ema_building_face_web

Flawed studies at Semler Research Centre calls for suspension of medicines, EMA recommends

July 25, 2016 Manufacturing and Production, Sales and Marketing EMA, Novartis, Teva, manufacturing, semler

Following an FDA inspection and WHO investigation earlier this year, the European Medicines Agency (EMA) has recommended the suspension of …
News
merckwindow

400 current and former employees join sexual discrimination lawsuit against MSD

July 25, 2016 Research and Development, Sales and Marketing MSD, Merck, discrimination, lawsuit

Over 400 women have come forward to join a $250 million gender bias class action against MSD, called Merck in …
News
abbvie_0

AbbVie scores EU recommendation for shorter treatment of Viekirax in hepatitis C

July 25, 2016 Research and Development, Sales and Marketing EU, Gilead, Viekirax, hepatitis C

AbbVie has received an EU recommendation for a shorter treatment duration of Viekirax (ombitasvir/paritaprevir/ritonavir) plus ribavirin in genotype 4 chronic …
News
gilead-sciences

EU recommends PrEP in Gilead’s HIV prevention treatment

July 25, 2016 Research and Development, Sales and Marketing EU, Gilead, HIV, PrEP, prevention

Gilead has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines …
News
shire_image

Shire receives positive EU opinion for pancreatic cancer drug

July 25, 2016 Research and Development, Sales and Marketing CHMP, EU, Pancreatic cancer, Shire

Shire has announced that the EU regulator’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion …
News
ema_inside

EMA recommends two new treatments for advanced kidney cancer

July 22, 2016 Research and Development, Sales and Marketing EMA, Eisai, renal cell carcinoma

The European Medicines Agency (EMA) has recommended two new medicines for the treatment of advanced renal cell carcinoma, or kidney …
News
needles

Valeant receives complete response letter from FDA on glaucoma drug

July 22, 2016 Medical Communications, Sales and Marketing FDA, Glaucoma, Valeant

Valeant Pharmaceuticals has announced that it has received a complete response letter from the FDA rejecting their new drug application …
News
biogen_austria_238

George Scangos to step down as Biogen CEO

July 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, George Scangos

In a surprising move, Biogen used the publishing of some promising second quarter results to announce the departure of CEO …
News
dollars_medicines

Galenica announces $1.53 billion Replysa acquisition

July 21, 2016 Research and Development, Sales and Marketing Relypsa, Vifor pharma, galenica

Galenica has announced that it has entered into an agreement to acquire Relypsa in a deal worth $1.53 billion, which …
News
roche_dark_0

Roche beats forecasts in strong H1 results

July 21, 2016 Research and Development, Sales and Marketing 2016, Q2, Roche, h1, results

Roche has published very encouraging full results for the first half of this year, with cancer drug sales helping to …
News
c_lucian_milasan_ebr_jan_2015_dublin

New Irish pharma deal to save €750 million, says minister

July 20, 2016 Sales and Marketing Ireland, Irish Pharmaceutical Healthcare Association

The Irish government has struck a deal with pharmaceutical manufacturers regarding the price and supply of medicines, which is expected …
News
lab

NICE recommends PTC Therapeutics Duchenne muscular dystrophy treatment

July 20, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, PTC Therapeutics

PTC Therapeutics has announced that the National Institute for Health and Care Excellence has issued final guidance recommending Translarna (ataluren) …
News
astrazeneca_crestor_rosuvastatin_40mg

AstraZeneca loses legal bid to block Crestor generics

July 20, 2016 Research and Development, Sales and Marketing AstraZeneca, Crestor, FDA, generics, legal

A US district court judge has refused AstraZeneca’s request for a temporary restraining order blocking the approval of generic versions …
News

Bristol-Myers Squibb settle $30 million California kickback lawsuit

July 20, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, california, lawsuit

Bristol-Myers Squibb (BMS) has agreed to pay $30 million to the California Department of Insurance to settle an almost decade …
News
doc_writing

FDA panel unanimously recommends approval of Valeant’s brodalumab with conditions

July 20, 2016 Research and Development, Sales and Marketing FDA, Valeant, brodalumab

Valeant has announced that the US Food and Drug Administration’s (FDA) dermatologic and ophthalmic drugs advisory committee has recommended brodalumab …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026